Monday, February 13, 2012
Introducing Mood 24/7, a new tool that helps you track your mood from day to day using your mobile phone. Try it today!

FDA panel recommends new bipolar, schizophrenia drug

(Medical News Today) UPDATED 2009-07-31
An expert panel that advises the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend a new drug for bipolar I disorder and schizophrenia. The drug, Saphris, was found to safe and effective for the acute treatment of manic or mixed episodes associated with bipolar I disorder, as well as for the acute treatment of schizophrenia in adults. If eventually approved by the FDA, Saphris would be the first drug approved for both indications.  Read full story >
See all Bipolar News